NeuroSense Therapeutics Ltd.

NRSNNASDAQ Capital Market·USD·Closed

NRSNNASDAQ·USD·Closed

$0.73

−3.78%

$0.73

−$0.03 (3.78%)

52W Range

5thpctl

Volume

0.88×avg

Mkt Cap

18.04MUSD

P/E

-2.9TTM

Div Yield

–ann

Healthcare · Biotechnology

52W Range

5thpercentile

Volume

0.88×avg

Market Cap

18.04MUSD

P/E Ratio

-2.9TTM

Loading chart data...

Current state

The verdict

Good business

Mixed

Revenue growth+0.0% / yr

Operating margin0.0%

ROIC465.0%

Financially safe

Stretched

Debt / equity-0.11×

Interest coverage-137.5×

Current ratio0.31×

Continue with finqOS

Unlock the full picture

SEC filings, earnings transcripts, insider trades, institutional ownership, 175+ screening metrics, and an infinite research canvas.

14-day free trial · No credit card required